Skip to main content

Table 2 Final drug concentrations, log10 [M]

From: Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer

Drugs

[C] low

[C] medium

[C] high

5FU

-7

-6.25

-5.5

Azacitidine

-6.5

-5.75

-5

Bortesomib

-9.25

-8.5

-7.75

Carboplatin

-6.25

-5.5

-4.75

Cobimetinib

-8

-7.25

-6.5

Docetaxel

-9.25

-8.75

-8.25

Doxorubicin

-8

-7.25

-6.5

Etoposide

-6.75

-6

-5.25

Everolimus

-8.5

-7.75

-7

Fludarabine

-8

-7.25

-6.5

Gefetinib

-7.5

-6.75

-6

Gemcitabine

-7.5

-6.75

-6

Lapatinib

-7

-6.25

-5.5

Mitomycin

-8

-7.25

-6.5

Olaparib

-6.5

-5.75

-5

Oxaliplatin

-6.5

-5.75

-5

Paclitaxel

-9

-8.5

-8

Pemetrexed

-8.25

-7.5

-6.75

Raltitrexed

-9

-8.5

-8

Regorafenib

-6.5

-5.75

-5

SN-38

-9

-8.5

-8

Sunitinib

-7

-6.5

-6

Trifluridin-tipiracil

-6.5

-5.75

-5

Vinorelbine

-8.75

-8

-7.25

Vorinostat

-6.75

-6.25

-5.75